Cargando…

High expression of FGFR3 predicts a better prognosis for patients with non-small cell lung cancer in a Chinese population

BACKGROUND: This study sought to examine the expression and mutation status of fibroblast growth factor receptor 3 (FGFR3) in non-small cell lung cancer (NSCLC) tissues and explore the prognostic potential of FGFR3 in NSCLC. METHODS: Immunohistochemistry (IHC) was used to evaluate the FGFR3 protein...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Yun-En, Long, Hui-Dong, Chen, Cheng-Cong, Liu, Guan-Cheng, Li, Feng, Tian, Yun-Hong, Dai, Lu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	AME Publishing Company 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922600/ https://www.ncbi.nlm.nih.gov/pubmed/36794128 http://dx.doi.org/10.21037/jtd-22-1523

Ejemplares similares

Lower mutant-allele tumor heterogeneity is a biomarker in FGFR3-mutant bladder cancer for better prognosis
por: Han, Yuying, et al.
Publicado: (2020)

The clinical pathological characteristics and prognosis of FGFR1 gene amplification in non-small-cell lung cancer: a meta-analysis
por: Xie, Fa-Jun, et al.
Publicado: (2016)

mRNA Expression of FGFR1 as Potential Marker for Predicting Prognosis of Surgical Resection of Small Cell Lung Cancer may be better than Protein Expression and Gene Amplification
por: Qin, Jing, et al.
Publicado: (2020)

FGFR1 promotes the stem cell-like phenotype of FGFR1-amplified non-small cell lung cancer cells through the Hedgehog pathway
por: Ji, Wenxiang, et al.
Publicado: (2016)

FGF2/FGFR1 regulates autophagy in FGFR1-amplified non-small cell lung cancer cells
por: Yuan, Hong, et al.
Publicado: (2017)

Targeting FGFR in non-small cell lung cancer: implications from the landscape of clinically actionable aberrations of FGFR kinases
por: Zhou, Zhen, et al.
Publicado: (2021)

Complex ALK Fusions Are Associated With Better Prognosis in Advanced Non-Small Cell Lung Cancer
por: Kang, Jin, et al.
Publicado: (2020)

The association of genetic variants in FGFR2 with osteoporosis susceptibility in Chinese Han population
por: Yang, Yang, et al.
Publicado: (2019)

FGFR1, 2 and 3 protein overexpression and molecular aberrations of FGFR3 in early stage non‐small cell lung cancer
por: Theelen, Willemijn SME, et al.
Publicado: (2016)

Intrinsic FGFR2 and Ectopic FGFR1 Signaling in the Prostate and Prostate Cancer
por: Wang, Cong, et al.
Publicado: (2019)

FGFR1 Is Associated With Tamoxifen Resistance and Poor Prognosis of ER-Positive Breast Cancers by Suppressing ER Protein Expression
por: Lv, Qing, et al.
Publicado: (2021)

Association of FGFR3 and FGFR4 gene polymorphisms with breast cancer in Chinese women of Heilongjiang province
por: Jiang, Yongdong, et al.
Publicado: (2015)

C1632 suppresses the migration and proliferation of non‐small‐cell lung cancer cells involving LIN28 and FGFR1 pathway
por: Chen, Jing‐yi, et al.
Publicado: (2021)

Apert Syndrome With FGFR2 758 C > G Mutation: A Chinese Case Report
por: Li, Yahong, et al.
Publicado: (2018)

Cytoplasmic Kaiso is associated with poor prognosis in non-small cell lung cancer
por: Dai, Shun-Dong, et al.
Publicado: (2009)

The genetic difference between Western and Chinese urothelial cell carcinomas: infrequent FGFR3 mutation in Han Chinese patients
por: Yuan, Xiaotian, et al.
Publicado: (2016)

Inhibitor-Sensitive FGFR1 Amplification in Human Non-Small Cell Lung Cancer
por: Dutt, Amit, et al.
Publicado: (2011)

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer
por: Zarczynska, Izabela, et al.
Publicado: (2021)

The Younger Patients Have More Better Prognosis in Limited Disease Small Cell Lung Cancer
por: Kim, Hye-Jin, et al.
Publicado: (2016)

Mutation patterns and evolutionary action score of TP53 enable identification of a patient population with poor prognosis in advanced non‐small cell lung cancer
por: Jiang, Wensheng, et al.
Publicado: (2022)

Further observations on the relationship between the FGFR4 Gly388Arg polymorphism and lung cancer prognosis
por: Matakidou, A, et al.
Publicado: (2007)

Down-regulation of NKD1 increases the invasive potential of non-small-cell lung cancer and correlates with a poor prognosis
por: Zhang, Sheng, et al.
Publicado: (2011)

Genetic variations in miR‐125 family and the survival of non‐small cell lung cancer in Chinese population
por: Wu, Shuangshuang, et al.
Publicado: (2019)

A Functional Polymorphism in Accessible Chromatin Region Confers Risk of Non-Small Cell Lung Cancer in Chinese Population
por: Long, Jieyi, et al.
Publicado: (2021)

The polymorphisms of FGFR2 and MGAT5 affect the susceptibility to COPD in the Chinese people
por: Li, Xiaobo, et al.
Publicado: (2021)

Tumor-associated inflammatory microenvironment in non-small cell lung cancer: correlation with FGFR1 and TLR4 expression via PI3K/Akt pathway
por: Zhang, Ruhui, et al.
Publicado: (2019)

FGFR inhibitors combined with nab-paclitaxel - A promising strategy to treat non-small cell lung cancer and overcome resistance
por: Ma, Feng, et al.
Publicado: (2023)

Normal lung attenuation distribution and lung volume on computed tomography in a Chinese population
por: Cheng, Ting, et al.
Publicado: (2019)

Association Between Triglyceride Glucose Index and Non-Small Cell Lung Cancer Risk in Chinese Population
por: Yan, Xin, et al.
Publicado: (2021)

Prognostic role of FGFR1 amplification in early-stage non-small cell lung cancer
por: Cihoric, N, et al.
Publicado: (2014)

FGFR1 regulates proliferation and metastasis by targeting CCND1 in FGFR1 amplified lung cancer
por: Yang, Ying, et al.
Publicado: (2020)

Changes in serum amino acid levels in non-small cell lung cancer: a case-control study in Chinese population
por: Liu, Ke, et al.
Publicado: (2022)

Significance of the FGFR3 mutation in Chinese patients with bladder cancer
por: Hao, Lanxiang, et al.
Publicado: (2023)

Sprouty2 suppresses progression and correlates to favourable prognosis of intrahepatic cholangiocarcinoma via antagonizing FGFR2 signalling
por: Xu, Yun‐Fei, et al.
Publicado: (2018)

FGFR aberrations increase the risk of brain metastases and predict poor prognosis in metastatic breast cancer patients
por: Xie, Ning, et al.
Publicado: (2020)

Progression Patterns, Treatment, and Prognosis Beyond Resistance of Responders to Immunotherapy in Advanced Non-Small Cell Lung Cancer
por: Xu, Yanjun, et al.
Publicado: (2021)

Correlation of FGFR2 rs2981582 polymorphisms with susceptibility to breast cancer: a case-control study in a Chinese population
por: Shu, Jin, et al.
Publicado: (2019)

Targeting FGFR overcomes EMT-mediated resistance in EGFR mutant non-small cell lung cancer
por: Raoof, Sana, et al.
Publicado: (2019)

The complete chloroplast genome of Verbascum thapsus L. (Scrophulariaceae) and its phylogenetic affinities
por: Zhang, Yue, et al.
Publicado: (2022)

Drug-sensitive FGFR3 mutations in lung adenocarcinoma
por: Chandrani, P., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_li2l7dcmct56qfkpsgoadurk2u